keyword
https://read.qxmd.com/read/38623015/-analysis-of-clinical-characteristic-of-pediatric-with-progressive-familial-intrahepatic-cholestasis-type-3
#21
JOURNAL ARTICLE
L L Cao, J G Yan, D N Feng, Y Dong, Z Q Xu, F C Wang, Y J Gao, S S Zhu, M Zhang
Objective: To analyze the clinical manifestations, pathology, and gene variant characteristics in children with progressive familial intrahepatic cholestasis type 3 (PFIC3). Methods: This retrospective study assessed the clinical manifestations, pathological features, gene variants, and prognosis data of 11 children with PFIC3 hospitalized in the Department of Hepatology, Fifth Medical Center, PLA General Hospital, from January 2015 to December 2022. Panel or whole exome sequencing was performed on the probands, followed by Sanger sequencing for verification within the family...
April 16, 2024: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics
https://read.qxmd.com/read/38622837/congenital-disorders-of-glycosylation-with-multiorgan-disruption-and-immune-dysregulation-caused-by-compound-heterozygous-variants-in-man2b2
#22
JOURNAL ARTICLE
Shiqi Fan, Huanhuan Wu, Rongrong Wang, Qian Chen, Xue Zhang
BACKGROUND: Congenital disorders of glycosylation (CDG) are a type of inborn error of metabolism (IEM) resulting from defects in glycan synthesis or failed attachment of glycans to proteins or lipids. One rare type of CDG is caused by homozygous or compound heterozygous loss-of-function variants in mannosidase alpha class 2B member 2 (MAN2B2). To date, only two cases of MAN2B2-CDG have been reported worldwide. METHODS: Trio whole-exome sequencing (Trio-WES) was conducted to screen for candidate variants...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38622473/evaluation-of-the-patients-with-the-diagnosis-of-pontocerebellar-hypoplasia-a-multicenter-national-study
#23
JOURNAL ARTICLE
Dilek Cavusoglu, Gulten Ozturk, Dilsad Turkdogan, Semra Hiz Kurul, Uluc Yis, Mustafa Komur, Faruk Incecik, Bulent Kara, Turkan Sahin, Olcay Unver, Cengiz Dilber, Gulen Gul Mert, Cagatay Gunay, Gamze Sarikaya Uzan, Ozlem Ersoy, Yavuz Oktay, Serdar Mermer, Gokcen Oz Tuncer, Olcay Gungor, Gul Demet Kaya Ozcora, Ugur Gumus, Ozlem Sezer, Gokhan Ozan Cetin, Fatma Demir, Arzu Yilmaz, Gurkan Gurbuz, Meral Topcu, Haluk Topaloglu, Ahmet Cevdet Ceylan, Serdar Ceylaner, Joseph G Gleeson, Dilara Fusun Icagasioglu, F Mujgan Sonmez
Pontocerebellar hypoplasia (PCH) is a heterogeneous group of neurodegenerative disorders characterized by hypoplasia and degeneration of the cerebellum and pons. We aimed to identify the clinical, laboratory, and imaging findings of the patients with diagnosed PCH with confirmed genetic analysis. We collected available clinical data, laboratory, and imaging findings in our retrospective multicenter national study of 64 patients with PCH in Turkey. The genetic analysis included the whole-exome sequencing (WES), targeted next-generation sequencing (NGS), or single gene analysis...
April 15, 2024: Cerebellum
https://read.qxmd.com/read/38622440/identification-of-a-novel-homozygous-gls-gene-variant-associated-with-developmental-and-epileptic-encephalopathy-dee-type-71
#24
JOURNAL ARTICLE
Afsaneh Bazgir, Mehdi Agha Gholizadeh, Seyyed Mohammad Kahani, Ali Reza Tavasoli, Masoud Garshasbi
Developmental and epileptic encephalopathy (DEEs) (OMIM#618,328) is characterized by seizures, hypotonia, and brain abnormalities, often arising from mutations in genes crucial for brain function. Among these genes, GLS stands out due to its vital role in the central nervous system (CNS), with homozygous variants potentially causing DEE type 71. Using Whole Exome Sequencing (WES) on a patient exhibiting symptoms of epileptic encephalopathy, we identified a novel homozygous variant, NM_014905.5:c.1849G > T; p...
April 15, 2024: Neurogenetics
https://read.qxmd.com/read/38619751/establishment-characterization-and-biobanking-of-36-pancreatic-cancer-organoids-prediction-of-metastasis-in-resectable-pancreatic-cancer
#25
JOURNAL ARTICLE
Soon-Chan Kim, Ha-Young Seo, Ja-Oh Lee, Ju Eun Maeng, Young-Kyoung Shin, Sang Hyub Lee, Jin-Young Jang, Ja-Lok Ku
PURPOSE: Early dissemination of primary pancreatic ductal adenocarcinoma (PDAC) is the main cause of dismal prognosis as it highly limits possible treatment options. A number of PDAC patients experience distant metastasis even after treatment due to the metastatic clones. We aimed to demonstrate the molecular architecture of borderline resectable PDAC manifests cancer dissemination of PDAC. METHODS: Here, 36 organoids isolated from primary tumor masses of PDAC patients with diverse metastatic statues are presented...
April 15, 2024: Cellular Oncology (Dordrecht)
https://read.qxmd.com/read/38619706/broadening-the-phenotype-and-genotype-spectrum-of-glycogen-storage-disease-by-unraveling-novel-variants-in-an-iranian-patient-cohort
#26
JOURNAL ARTICLE
Parinaz Moghimi, Farzad Hashemi-Gorji, Sanaz Jamshidi, Sahand Tehrani Fateh, Shadab Salehpour, Hossein Sadeghi, Fatemeh Norouzi Rostami, Reza Mirfakhraie, Mohammad Miryounesi, Mohammad-Reza Ghasemi
Glycogen storage diseases (GSDs) are a group of rare inherited metabolic disorders characterized by clinical, locus, and allele heterogeneity. This study aims to investigate the phenotype and genotype spectrum of GSDs in a cohort of 14 families from Iran using whole-exome sequencing (WES) and variant analysis. WES was performed on 14 patients clinically suspected of GSDs. Variant analysis was performed to identify genetic variants associated with GSDs. A total of 13 variants were identified, including six novel variants, and seven previously reported pathogenic variants in genes such as AGL, G6PC, GAA, PYGL, PYGM, GBE1, SLC37A4, and PHKA2...
April 15, 2024: Biochemical Genetics
https://read.qxmd.com/read/38619582/-molecular-pathological-analysis-through-the-ages
#27
REVIEW
Maria Walker, Eva-Maria Mayr, Mai-Lan Koppermann, Ana Terron, Yoko Wagner, Charlotte Kling, Nicole Pfarr
BACKGROUND: Molecular pathological examinations of tumor samples encompass a wide range of diagnostic analyses. Especially in recent years, numerous new biomarkers have come to the forefront-the analysis of which is crucial for therapy decisions. OBJECTIVES: Within the field of molecular pathology, the demands of next generation sequencing (NGS)-based requirements have experienced massive growth in recent years. To meet this demand, methods are constantly being adapted and further developed...
April 15, 2024: Pathologie (Heidelb)
https://read.qxmd.com/read/38619019/-prps1-associated-retinopathy-a-diagnostic-odyssey
#28
JOURNAL ARTICLE
Tariq A Alzahem, Abdulwahab AlTheeb, Rola Ba-Abbad
PURPOSE: This study describes how the diagnosis of Usher syndrome was revised to PRPS1-associated retinopathy and Charcot-Marie-Tooth disease type 5. CASE REPORT: A 38-year-old female with bilaterally subnormal vision and non-congenital hearing loss was initially diagnosed with Usher syndrome, based on finding variants in three genes (MYO7A, USH2A, and PCDH15), was re-evaluated at the inherited retinal disorders clinic. She had asymmetric retinopathy and right macular pseudocoloboma...
April 15, 2024: Ophthalmic Genetics
https://read.qxmd.com/read/38618928/auriculocondylar-syndrome-2-caused-by-a-novel-plcb4-variant-in-a-male-chinese-neonate-a-case-report-and-review-of-the-literature
#29
JOURNAL ARTICLE
Yongli Zhang, Yuwei Zhao, Liying Dai, Yu Liu, Zifeng Shi
BACKGROUND: Auriculocondylar syndrome (ARCND) is a rare congenital craniofacial developmental malformation syndrome of the first and second pharyngeal arches with external ear malformation at the junction between the lobe and helix, micromaxillary malformation, and mandibular condylar hypoplasia. Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38618260/evaluation-of-the-genetic-background-of-patients-with-niemann-pick-disease
#30
JOURNAL ARTICLE
Fatemeh Alipouran, Ehsan Ghayoor Karimiani, Jina Khayatzadeh
BACKGROUND: Congenital liver disease refers to a group of heterogeneous diseases from a clinical genetic point of view. The most crucial features are hepatosplenomegaly and elevated liver enzymes. This study aims to identify genetic variants causing the disease in three Iranian families with congenital liver disease using molecular techniques. METHODS: Patients were referred to Next Generation Genetic Polyclinic (NGGC) in Mashhad after confirmed congenital liver disease diagnosis by gastroenterologists...
October 2023: Reports of Biochemistry & Molecular Biology
https://read.qxmd.com/read/38617633/deciphering-the-impact-of-rare-missense-variants-in-egfr-tki-resistant-non-small-cell-lung-cancer-through-whole-exome-sequencing-a-computational-approach
#31
JOURNAL ARTICLE
Ambritha Balasundaram, George Priya C Doss
Targeted therapy revolutionizes the treatment of non-small-cell lung cancer (NSCLC), harboring molecular change. Epidermal growth factor receptor (EGFR) mutations play a crucial role in the development of NSCLC, serving as a pivotal factor in its pathogenesis. We elucidated the mechanisms of resistance and potential therapeutic strategies in NSCLC resistant to the EGFR-tyrosine kinase inhibitor (EGFR-TKI). This is achieved by identifying rare missense variants through whole exome sequencing (WES). The goal is to enhance our understanding, identify biomarkers, and lay the groundwork for targeted interventions, thereby offering hope for an improved NSCLC treatment landscape...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38617480/clinical-and-molecular-heterogeneity-associated-with-tumor-sidedness-in-colorectal-liver-metastasis-a-multicenter-propensity-cohort-study
#32
JOURNAL ARTICLE
Yibin Wu, Jiamin Zhou, Huipeng Wang, Guojiu Fang, Weiping Zhu, Sanjun Cai, Lu Wang
BACKGROUND: Colorectal liver metastasis (CRLM) exhibits highly heterogeneity, with clinically and molecularly defined subgroups that differ in their prognosis. The aim of this study is to explore whether left-sided tumors is clinically and gnomically distinct from right-sided tumors in CRLM. METHODS: This retrospective study included 1,307 patients who underwent primary tumor and metastases resection at three academic centers in China from January 1, 2012, to December 31, 2020...
April 3, 2024: Hepatobiliary Surgery and Nutrition
https://read.qxmd.com/read/38617375/infantile-epileptic-spasms-syndrome-in-a-child-with-lissencephaly-associated-with-de-novo-pafah1b1-v-ariant-and-coincidental-cmv-infection
#33
Nga Ying Eng, Duyu A Nie
Type 1 lissencephaly is a brain malformation characterized by agyria and pachygyria and is known to be caused by congenital infections and genetic variations. Here we present a case of a 4-month-old female with new onset infantile epileptic spasms syndrome (IESS) with initial etiology concerned for congenital cytomegalovirus (cCMV) due to a positive urine CMV PCR and maternal viral syndrome during pregnancy. Her brain MRI was significant for type 1 lissencephaly without other radiographical features of cCMV...
2024: Epilepsy & behavior reports
https://read.qxmd.com/read/38616208/integrated-analysis-of-single-cell-rna-seq-and-bulk-rna-seq-reveals-immune-suppression-subtypes-and-establishes-a-novel-signature-for-determining-the-prognosis-in-lung-adenocarcinoma
#34
JOURNAL ARTICLE
Shengqiang Mao, Yilong Wang, Ningning Chao, Lingyan Zeng, Li Zhang
BACKGROUND: Lung adenocarcinoma (LUAD) is the most common histological type of lung cancer with lower survival rates. Recent advancements in targeted therapies and immunotherapies targeting immune checkpoints have achieved remarkable success, there is still a large percentage of LUAD that lacks available therapeutic options. Due to tumor heterogeneity, the diagnosis and treatment of LUAD are challenging. Exploring the biology of LUAD and identifying new biomarker and therapeutic targets options are essential...
April 15, 2024: Cellular Oncology (Dordrecht)
https://read.qxmd.com/read/38615286/incidence-and-molecular-characteristics-of-deficient-mismatch-repair-conditions-across-nine-different-tumors-and-identification-of-germline-variants-involved-in-lynch-like-syndrome
#35
JOURNAL ARTICLE
Tetsuya Ito, Tatsuro Yamaguchi, Kensuke Kumamoto, Okihide Suzuki, Noriyasu Chika, Satoru Kawakami, Tomonori Nagai, Tsukasa Igawa, Kenji Fujiyoshi, Yoshito Akagi, Tomio Arai, Kiwamu Akagi, Hidetaka Eguchi, Yasushi Okazaki, Hideyuki Ishida
BACKGROUND: Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. METHODS: We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors...
April 14, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38614322/molecular-characterization-of-juxtaglomerular-cell-tumors-evidence-of-alterations-in-mapk-ras-pathway
#36
JOURNAL ARTICLE
João Lobo, Sofia Canete-Portillo, Maria Del Carmen Rodriguez Pena, Jesse K McKenney, Manju Aron, Felipe Massicano, Brandon M Wilk, Manavalan Gajapathy, Donna M Brown, Dilek E Baydar, Andres Matoso, Nathalie Rioux-Leclerq, Chin-Chen Pan, Maria S Tretiakova, Kiril Trpkov, Sean R Williamson, Soroush Rais-Bahrami, Alexander C Mackinnon, Shuko Harada, Elizabeth A Worthey, Cristina Magi-Galluzzi
Juxtaglomerular cell tumor (JGCT) is a rare neoplasm, part of the family of mesenchymal tumors of the kidney. Although the pathophysiological and clinical correlates of JGCT are well-known, as these tumors are an important cause of early-onset arterial hypertension refractory to medical treatment, their molecular background is unknown, with only few small studies investigating their karyotype. Herein we describe a multi-institutional cohort of JGCTs diagnosed by experienced genitourinary pathologists, evaluating clinical presentation and outcome, morphologic diversity and, importantly, the molecular features...
April 11, 2024: Modern Pathology
https://read.qxmd.com/read/38614108/rab32-ser71arg-in-autosomal-dominant-parkinson-s-disease-linkage-association-and-functional-analyses
#37
JOURNAL ARTICLE
Emil K Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D Fox, Silke Appel-Cresswell, A Jon Stoessl, Alex Rajput, Ali H Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B Haack, Suzanne Lesage, Christelle Tesson, Alexis Brice, Carles Vilariño-Güell, Mina Ryten, Matthew S Goldberg, Andrew B West, Michele T Hu, Huw R Morris, Manu Sharma, Ziv Gan-Or, Bedia Samanci, Pawel Lis, Maria Teresa Periñan, Rim Amouri, Samia Ben Sassi, Faycel Hentati, Francesca Tonelli, Dario R Alessi, Matthew J Farrer
BACKGROUND: Parkinson's disease is a progressive neurodegenerative disorder with multifactorial causes, among which genetic risk factors play a part. The RAB GTPases are regulators and substrates of LRRK2, and variants in the LRRK2 gene are important risk factors for Parkinson's disease. We aimed to explore genetic variability in RAB GTPases within cases of familial Parkinson's disease. METHODS: We did whole-exome sequencing in probands from families in Canada and Tunisia with Parkinson's disease without a genetic cause, who were recruited from the Centre for Applied Neurogenetics (Vancouver, BC, Canada), an international consortium that includes people with Parkinson's disease from 36 sites in 24 countries...
April 10, 2024: Lancet Neurology
https://read.qxmd.com/read/38613342/identification-and-characterization-of-novel-genetic-variants-in-the-first-chinese-family-of-mucopolysaccharidosis-iiic-sanfilippo-c-syndrome
#38
JOURNAL ARTICLE
Hongjun Zhao, Lijing Wang, Mengfei Zhang, Huakun Wang, Sizhe Zhang, Junjiao Wu, Yu Tang
Mucopolysaccharidosis type IIIC (MPS IIIC) is one of inherited lysosomal storage disorders, caused by deficiencies in lysosomal hydrolases degrading acidic mucopolysaccharides. The gene responsible for MPS IIIC is HGSNAT, which encodes an enzyme that catalyses the acetylation of the terminal glucosamine residues of heparan sulfate. So far, few studies have focused on the genetic landscape of MPS IIIC in China, where IIIA and IIIB were the major subtypes. In this study, we utilized whole-exome sequencing (WES) to identify novel compound heterozygous variants in the HGSNAT gene from a Chinese patient with typical MPS IIIC symptoms: c...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38613257/late-onset-kjellin-syndrome-diagnosis-of-spg11-on-fundus-examination
#39
JOURNAL ARTICLE
Vincent Brock, Anna Wissocq, Nicolas Geoffre, Caroline Marks, Vincent Canel, Vincent Huin, Vasily M Smirnov
INTRODUCTION: Spastic paraplegia (SPG) is a heterogenous group of neurodegenerative disorders, that may include ocular involvement. Here we report the clinical data of a patient with late-onset Kjellin syndrome, a peculiar form of hereditary SPG with macular dystrophy. MATERIALS AND METHODS: Clinical, functional and multimodal retinal imaging data were collected. Genetic testing was performed by Whole Exome Sequencing (WES). RESULTS: A 52-year-old female patient with SPG of unknown origin was referred for a progressive visual acuity loss...
April 13, 2024: European Journal of Ophthalmology
https://read.qxmd.com/read/38611048/identification-of-two-distinct-immune-subtypes-in-hepatitis-b-virus-hbv-associated-hepatocellular-carcinoma-hcc
#40
JOURNAL ARTICLE
Davide De Battista, Rylee Yakymi, Evangeline Scheibe, Shinya Sato, Hannah Gerstein, Tovah E Markowitz, Justin Lack, Roberto Mereu, Cristina Manieli, Fausto Zamboni, Patrizia Farci
HBV is the most common risk factor for HCC development, accounting for almost 50% of cases worldwide. Despite significant advances in immunotherapy, there is limited information on the HBV-HCC tumor microenvironment (TME), which may influence the response to checkpoint inhibitors. Here, we characterize the TME in a unique series of liver specimens from HBV-HCC patients to identify who might benefit from immunotherapy. By combining an extensive immunohistochemistry analysis with the transcriptomic profile of paired liver samples (tumor vs...
March 30, 2024: Cancers
keyword
keyword
24602
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.